235 related articles for article (PubMed ID: 34669455)
1. Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic Infections.
Yansouni CP; Papenburg J; Cheng MP; Corsini R; Caya C; Vasquez Camargo F; Harrison LB; Zaharatos G; Büscher P; Faye B; Ndiaye M; Matlashewski G; Ndao M
J Clin Microbiol; 2022 Jan; 60(1):e0171721. PubMed ID: 34669455
[TBL] [Abstract][Full Text] [Related]
2. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
Harley K; Gunsolus IL
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
[TBL] [Abstract][Full Text] [Related]
4. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay.
Batra R; Olivieri LG; Rubin D; Vallari A; Pearce S; Olivo A; Prostko J; Nebbia G; Douthwaite S; Rodgers M; Cloherty G
J Clin Virol; 2020 Nov; 132():104645. PubMed ID: 32961429
[TBL] [Abstract][Full Text] [Related]
9. Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests.
Rodgers MA; Olivo A; Harris BJ; Lark C; Luo X; Berg MG; Meyer TV; Mohaimani A; Orf GS; Goldstein Y; Fox AS; Hirschhorn J; Glen WB; Nolte F; Landay A; Jennings C; Moy J; Servellita V; Chiu C; Batra R; Snell LB; Nebbia G; Douthwaite S; Tanuri A; Singh L; de Oliveira T; Ahouidi A; Mboup S; Cloherty GA
J Clin Virol; 2022 Feb; 147():105080. PubMed ID: 35086043
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study.
Peghin M; Bontempo G; De Martino M; Palese A; Gerussi V; Graziano E; Fabris M; D'Aurizio F; Sbrana F; Ripoli A; Curcio F; Isola M; Tascini C
BMC Infect Dis; 2022 Oct; 22(1):810. PubMed ID: 36316641
[TBL] [Abstract][Full Text] [Related]
11. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
12. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
[TBL] [Abstract][Full Text] [Related]
13. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
[TBL] [Abstract][Full Text] [Related]
15. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
Al-Mughales JA; Al-Mughales TJ; Saadah OI
Front Immunol; 2021; 12():705441. PubMed ID: 34539635
[TBL] [Abstract][Full Text] [Related]
16. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
[TBL] [Abstract][Full Text] [Related]
17. Validation and performance comparison of three SARS-CoV-2 antibody assays.
Paiva KJ; Grisson RD; Chan PA; Huard RC; Caliendo AM; Lonks JR; King E; Tang EW; Pytel-Parenteau DL; Nam GH; Yakirevich E; Lu S
J Med Virol; 2021 Feb; 93(2):916-923. PubMed ID: 32710669
[TBL] [Abstract][Full Text] [Related]
18. Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.
O'Kelly B; McLaughlin R; O'Doherty R; Carroll H; Murray R; Dilworth R; Corkery L; Cotter AG; McGinty T; Muldoon EG; Cullen W; Avramovic G; Sheehan G; Sadlier D; Higgins M; O'Gorman P; Doran P; Inzitari R; Holden S; O'Meara Y; Ennis S; Lambert JS
Front Med (Lausanne); 2021; 8():642318. PubMed ID: 34513853
[No Abstract] [Full Text] [Related]
19. The role and diagnostic accuracy of serology for COVID-19.
Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
[TBL] [Abstract][Full Text] [Related]
20. Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests.
Maine GN; Krishnan SM; Walewski K; Trueman J; Sykes E; Sun Q
J Immunol Methods; 2022 Apr; 503():113243. PubMed ID: 35181288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
